Steve Gleason's Current Net Worth and Financial Standing
Steve Gleason's estimated net worth is around $3 million to $5 million, according to public financial reporting and celebrity net worth aggregators. His wealth stems primarily from his NFL career, media appearances, and his advocacy work through the Steve Gleason Foundation. He has also generated income from public speaking and documentary projects, including the acclaimed film "Gleason."
Gleason's financial profile has been shaped by his long battle with ALS, which has led to significant medical expenses. His foundation, Team Gleason, has raised millions to support people with the disease. Despite these costs, his net worth remains stable, supported by his NFL pension and ongoing media royalties.
Career Highlights and Public Recognition
Steve Gleason played eight seasons in the NFL, primarily as a special teams player for the New Orleans Saints from 2001 to 2008. He is best known for a blocked punt in the Saints' first home game after Hurricane Katrina, a moment that became a symbol of resilience. His career statistics include over 200 special teams tackles and multiple Pro Bowl selections.
After retiring, Gleason transitioned into advocacy and filmmaking. His documentary "Gleason," released in 2016, received critical acclaim and brought national attention to ALS. He was awarded the Congressional Gold Medal in 2024 for his advocacy, one of the highest civilian honors in the United States. His work has been recognized by organizations like the ALS Association and the Michael J. Fox Foundation.
Health Status and ALS Advocacy
Steve Gleason was diagnosed with ALS, also known as Lou Gehrig's disease, in 2011. The diagnosis was initially kept private but was later shared publicly to raise awareness. He has used eye-tracking technology to communicate and continues to advocate for research and support for people with ALS.
His advocacy has led to significant legislative and public awareness victories. The Steve Gleason Act, which ensures Medicare coverage for speech-generating devices, was signed into law in 2015. He continues to lead Team Gleason, which provides grants, technology, and support to thousands of individuals living with ALS worldwide. His efforts have been highlighted by major outlets like Forbes and The New York Times.